Summary
A Nature Medicine research briefing reports that colorectal tumours in younger adults contain more stromal cells and show higher expression of long non-coding RNAs and genes linked to epithelial-to-mesenchymal transition. The findings come from a transcriptomic atlas mapping tumours across the age continuum.
A Nature Medicine research briefing reports that colorectal tumours in younger adults have more stromal cells and higher expression of long non-coding RNAs and genes associated with epithelial-to-mesenchymal transition (EMT). The findings come from a transcriptomic atlas comparing tumours across eight decades of life. The briefing notes that the incidence of early-onset colorectal cancer is rising, while the biology distinguishing it from disease at older ages has been uncertain.
What the atlas found
The associated research article describes a single-nucleus RNA-sequencing atlas. This method measures RNA in individual cell nuclei, helping researchers compare gene activity and the types of cells present in tumour tissue. A transcriptome is the set of RNA molecules being expressed in a sample at a given time.
Across the age range, the briefing says tumours from younger adults contained a greater proportion of stromal cells. These are non-cancer cells that form part of the tissue surrounding and supporting a tumour. The younger patients’ tumours also showed increased expression of long non-coding RNAs—RNA molecules that do not encode proteins—and of genes associated with EMT, a programme in which cells can take on characteristics different from their usual epithelial state.
The reported differences span both tumour-cell gene activity and the mix of cells in tumour tissue. They suggest that age-related variation in colorectal cancer may involve more than a single genetic feature. The atlas provides a way to examine these patterns across age rather than treating younger and older patients as separate, isolated groups.
What the findings mean
The atlas identifies molecular patterns associated with younger age; it does not explain what causes them. In particular, higher expression of EMT-associated genes is evidence of a gene-activity pattern, not by itself proof that tumour cells underwent a particular change in behaviour. The findings offer a basis for further research into how tumour biology varies with age. The briefing describes a molecular atlas, rather than an assessment of a diagnostic test or treatment.